We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+13.82%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$13B
AUM Growth
+$1.56B
(+14%)
Cap. Flow
+$261M
Cap. Flow
% of AUM
2.02%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
1,179
New
174
Increased
377
Reduced
434
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$128M |
| 2 |
Electronic Arts
EA
|
+$79.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$75M |
| 4 |
Target
TGT
|
+$74.4M |
| 5 |
Amazon
AMZN
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Starbucks
SBUX
|
+$121M |
| 3 |
Micron Technology
MU
|
+$83M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$58.2M |
| 5 |
Kimberly-Clark
KMB
|
+$53.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.12% |
| 2 | Healthcare | 14.04% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Financials | 12.63% |
| 5 | Industrials | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DSPG
626
DELISTED
DSP Group Inc
DSPG
| $1.77M | 0.01% |
+124,419
| New | +$1.99M |
|
627
Lifecore Biomedical
LFCR
$162M
| $1.76M | 0.01% |
166,409
+94,064
| +130% | +$1.06M |
|
|
CDAK
628
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $1.75M | 0.01% |
115,859
+93,730
| +424% | +$2.04M |
|
|
ALTA
629
DELISTED
Altabancorp
ALTA
| $1.74M | 0.01% |
41,381
-2,692
| -6% | -$94.9K |
|
|
NVRO
630
DELISTED
NEVRO CORP.
NVRO
| $1.74M | 0.01% |
+12,460
| New | +$2.03M |
|
|
SBBP
631
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.73M | 0.01% |
625,568
+194,867
| +45% | +$588K |
|
|
MZTI
632
The Marzetti Company
MZTI
$3.05B
| $1.73M | 0.01% |
+9,844
| New | +$1.76M |
|
633
Genpact
G
$6.22B
| $1.72M | 0.01% |
+40,256
| New | +$1.67M |
|
634
Navient
NAVI
$819M
| $1.72M | 0.01% |
120,298
+45,612
| +61% | +$562K |
|
|
OPTN
635
DELISTED
OptiNose
OPTN
| $1.72M | 0.01% |
30,980
+29,873
| +2,699% | +$1.82M |
|
636
Puma Biotechnology
PBYI
$398M
| $1.7M | 0.01% |
174,693
+71,165
| +69% | +$795K |
|
637
EXL Service
EXLS
$5.5B
| $1.7M | 0.01% |
+94,000
| New | +$1.6M |
|
638
First Financial Corp
THFF
$948M
| $1.68M | 0.01% |
37,311
-1,493
| -4% | -$63.5K |
|
639
Savara
SVRA
$1.08B
| $1.64M | 0.01% |
787,650
+739,011
| +1,519% | +$1.26M |
|
|
ELVT
640
DELISTED
Elevate Credit, Inc.
ELVT
| $1.61M | 0.01% |
552,180
+287,650
| +109% | +$1.2M |
|
641
Community Trust Bancorp
CTBI
$1.42B
| $1.6M | 0.01% |
36,280
-136
| -0.4% | -$5.59K |
|
|
KIN
642
DELISTED
Kindred Biosciences, Inc.
KIN
| $1.6M | 0.01% |
321,040
+87,500
| +37% | +$423K |
|
643
Becton Dickinson
BDX
$46.4B
| $1.59M | 0.01% |
6,714
+5,416
| +417% | +$1.32M |
|
644
Insulet
PODD
$11.8B
| $1.59M | 0.01% |
6,079
-22,247
| -79% | -$5.96M |
|
|
CTO
645
CTO Realty Growth
CTO
$756M
| $1.57M | 0.01% |
90,441
-9,480
| -9% | -$154K |
|
646
Allient
ALNT
$1.34B
| $1.56M | 0.01% |
45,477
-1,853
| -4% | -$61.2K |
|
647
Meritage Homes
MTH
$4.78B
| $1.54M | 0.01% |
+33,624
| New | +$1.46M |
|
|
CMLS
648
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $1.52M | 0.01% |
166,885
+65,952
| +65% | +$647K |
|
649
Rambus
RMBS
$8.95B
| $1.52M | 0.01% |
78,094
-24,881
| -24% | -$500K |
|
650
Banc of California
BANC
$2.87B
| $1.51M | 0.01% |
+83,521
| New | +$1.55M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2021 Portfolio in Review
As of Q1 2021, Jacobs Levy Equity Management held 1,179 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management's Q1 2021 filing shows 174 new, 377 increased, 434 reduced and 179 closed positions. Its largest new stake was Target: 397,775 shares worth $78.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q1 2021 buy was Target: 397,775 shares worth $78.8M.
- Jacobs Levy Equity Management added most to Costco in Q1 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- Jacobs Levy Equity Management fully exited Starbucks in Q1 2021, selling an estimated $121M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $13B portfolio in Q1 2021.
- Jacobs Levy Equity Management opened 174 new positions and closed 179 in Q1 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $13B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2021, filed 17 May 2021.